BioCentury
ARTICLE | Clinical News

Sunshine Biopharma preclinical data

July 9, 2012 7:00 AM UTC

In vitro, Adva-27a killed significantly more multidrug-resistant SCLC tumor cells than generic etoposide. Adva-27a is a small molecule topoisomerase II (TOP2) inhibitor. ...